Type 2 diabetes currently features in headlines via GLP-1 drugs, cardiovascular links, and fiber intake strategies to manage blood sugar.
A string of developments around testosterone replacement therapy (TRT) has sparked a national conversation. The US military is considering testing service members’ testosterone levels and expanding access to TRT where clinically appropriate, while lawmakers and experts weigh safety, ethics and performance implications. Reports from AP News, CNBC, CNBC and other outlets indicate a widening trend in how TRT is discussed and regulated.
Eli Lilly has posted another quarter of strong results driven by Mounjaro and Zepbound, lifting full-year guidance. Novo Nordisk trails in growth momentum as it works to regain share and assure investors of a clear long-term path. Foundayo’s launch adds a new dimension to Lilly’s portfolio.
A wave of studies finds that AI analysis of mammograms can identify cardiovascular risks in women, including hypertension, coronary heart disease and stroke, alongside breast cancer screening. Researchers say mammograms could become a dual-purpose tool for early cardiovascular risk detection, prompting earlier intervention.
Dietitians highlight the health benefits of fiber and list high-fiber foods to boost gut health, with a focus on whole grains, beans, and plant-based meals. The conversations emphasize practical ways to reach 40–60 grams daily, citing research and expert opinion.
New observational data suggests Shingrix vaccination in older adults is associated with lower cardiovascular risk and reduced dementia incidence over multi-year follow-ups. Studies compare Shingrix to Zostavax and find reductions in heart disease, stroke, and dementia, with stronger signals in men for heart outcomes.
GLP-1 medications are being increasingly prescribed off-label to children aged 8–11 in the US, despite no FDA approval for under-12s. A NYU Langone study shows a dramatic rise in June 2026, while experts warn about long-term effects and the broader obesity crisis.
The NHS is expanding free cholesterol tests and blood pressure checks to adults aged 40 to 84 in participating high-street pharmacies after a north London pilot showed 19% at high risk and 88 people starting statins. The program aims to identify cardiovascular risk earlier and reduce pressure on GP and hospital services.
A set of recent articles highlights fiber intake shortfalls in the US and the growing emphasis on fiber-rich foods in the UK. Nutrition experts say increasing fiber can reduce heart disease, diabetes and certain cancers, with practical tips for breakfast and daily meals.